Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy.

ABSTRACT: In humans, a total of 12 galectins have been identified. Their intracellular and extracellular biological functions are explored and discussed in this review. These galectins play important roles in controlling immune responses within the tumour microenvironment (TME) and the infiltration of immune cells, including different subsets of T cells, macrophages, and neutrophils, to fight against cancer cells. However, these infiltrating cells also have repair roles and are hijacked by cancer cells for pro-tumorigenic activities. Upon a better understanding of the immunomodulating functions of galectin-3 and -9, their inhibitors, namely, GB1211 and LYT-200, have been selected as candidates for clinical trials. The use of these galectin inhibitors as combined treatments with current immune checkp

SUBMITTER: Ko FCF 

PROVIDER: S-EPMC10296743 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature